Osteoarthritis (OA), a common degenerative joint disease that affects millions of people worldwide, particularly targets the ...

This inexpensive generic significantly reduced knee pain in a small trial of people who are overweight or have obesity.

Pacira BioSciences has announced that its gene therapy candidate, PCRX-201 (enekinragene inzadenovec), has demonstrated ...

A 6-month study found moderate reductions in knee osteoarthritis pain in patients with overweight or obesity, independent of ...

A mainstay diabetes medication reduced pain and stiffness and improved function in overweight people with knee osteoarthritis ...

Osteoarthritis (OA) is a common joint condition that causes pain and limits movement, especially in the knees. It affects ...

People with osteoarthritis are more likely to have other pain-related and psychological conditions including depression, CFS, ...

Novartis has done a little spring cleaning, sweeping a phase 2 osteoarthritis prospect and first-in-human radioconjugate out of its pipeline after assessing evidence on the programs. | Novartis has ...

Researchers found yoga was noninferior to strengthening exercises for pain reduction in knee osteoarthritis, and provided ...

Australia: A new randomized clinical trial has demonstrated that metformin, a drug commonly used to manage type 2 diabetes, ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

Limited evidence has suggested that metformin could reduce some of the pathology underlying osteoarthritis (OA). Researchers conducted a small randomized trial to assess metformin's effectiveness ...